Baystate Wealth Management’s Amedisys AMED Stock Holding History

Baystate Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$285	Hold	3	–	–	﹤0.01%	1244
2023 Q3	$280	Hold	3	–	–	﹤0.01%	973
2023 Q2	$274	Hold	3	–	–	﹤0.01%	997
2023 Q1	$221	Hold	3	–	–	﹤0.01%	1002
2022 Q4	$0	Hold	3	–	–	﹤0.01%	935
2022 Q3	$0	Hold	3	–	–	﹤0.01%	881
2022 Q2	$0	Hold	3	–	–	﹤0.01%	897
2022 Q1	$1K	Sell	3 -3	-50%	-$448	﹤0.01%	798
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	799
2021 Q3	$1K	Hold	6	–	–	﹤0.01%	724
2021 Q2	$1K	Hold	6	–	–	﹤0.01%	695
2021 Q1	$2K	Buy	+6	New	+$1.69K	﹤0.01%	579

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Baystate Wealth Management's AMED Position: Q4 2023 in Review

Baystate Wealth Management held its Amedisys (AMED) position steady in Q4 2023 at 3 shares worth $285. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Baystate Wealth Management first reported a position in AMED in Q1 2021 and has held it in 12 quarters since. The position peaked at $2K in Q1 2021. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

Baystate Wealth Management held 3 shares of Amedisys worth $285 as of Q4 2023.
Baystate Wealth Management left its Amedisys share count unchanged in Q4 2023.
Amedisys made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1244 holding.
Baystate Wealth Management first reported a position in Amedisys in Q1 2021 and has held it in 12 quarters since.
Baystate Wealth Management's Amedisys position peaked at $2K in Q1 2021.
287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.